相关实验视频
Updated: Jun 24, 2025

06:21
Chinese Herbal Retention Enema for the Treatment of Ulcerative Colitis
Published on: May 16, 2025
99
急性严重性结肠炎的管理 - 一个通用和专业临床医生的更新
Anish J Kuriakose Kuzhiyanjal1, Jimmy K Limdi2,3
1Digestive Diseases Unit, Aintree University Hospital, Lower Ln, Fazakerley, Liverpool L97AL, UK.
British medical bulletin
|June 1, 2024
概括
急性严重性结肠炎 (ASUC) 的管理需要多学科的方法. 早期使用类固醇和及时升级到救援疗法或手术对于ASUC患者的更好的结果至关重要.
科学领域:
- 胃肠病学 胃肠病学
- 内部医学 内部医学
- 结肠直肠手术 结肠直肠手术
背景情况:
- 急性严重性结肠炎 (ASUC) 是一种危及生命的紧急情况,影响高达25%的性结肠炎患者.
- 静脉内皮质类固醇是标准的,但30-40%的患者需要救援疗法 (infliximab,环素) 或切除术.
- 多学科护理对于ASUC的良好结果至关重要.
研究的目的:
- 讨论关于ASUC管理的当前证据.
- 为临床医生提供一种管理ASUC的方法.
- 强调及时治疗升级的重要性.
主要方法:
- 对同行评审学术期刊的审查.
- 已注册临床试验的分析.
主要成果:
- ASUC管理需要一个多学科的方法.
- 早期的类固醇启动和及时的治疗升级 (医疗救援或手术) 是关键.
- 在推迟手术和优化包括生物药物在内的医疗治疗之间的最佳平衡是有争议的.
结论:
- 雅努斯激酶抑制剂对抗类固醇耐火性ASUC.表示有前途.
- 对个性化救援疗法的预测生物标志物和风险评分的研究正在进行中.
相关概念视频
Drugs for Treatment of Ulcerative Colitis in IBD
135
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
135
Inflammatory Bowel Disease I: Ulcerative Colitis
162
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
162
Inflammatory Bowel Disease V: Surgical Management
139
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
139
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
331
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
331
Peptic Ulcer Disease IV: Management
87
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
87
Inflammatory Bowel Disease IV: Pharmacological Management
126
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
126

